Omega-3 Fatty Acids (DHA/EPA) 관련 Mild Cognitive Impairment (MCI)
BResearch suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
<\/script>\n`;
},
get iframeSnippet() {
const domain = 'braincited.com';
const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment';
return ``;
},
get activeSnippet() {
return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet;
},
copySnippet() {
navigator.clipboard.writeText(this.activeSnippet).then(() => {
this.copied = true;
setTimeout(() => { this.copied = false; }, 2000);
});
}
}"
@keydown.escape.window="open = false"
@click.outside="open = false">
B
결론
Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.
Key Study Findings
Systematic Review
n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None
vs: Placebo or control
Outcome: Cognitive function in AD and MCI patients
효과: None
None
대상 집단: AD and MCI patients aged 50-90 (31 clinical trials)
Randomized Controlled Trial
n=73
12 weeks
Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily
vs: IL triamcinolone acetonide alone
Outcome: Hair density (regrowth scale)
효과: None
0.018 (scalp subgroup at wk12)
대상 집단: Patients with scalp and beard alopecia areata (179 patches)
Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None
vs: None
Outcome: Cognitive outcomes (memory, executive function)
효과: None
None
대상 집단: Aging adults with cognitive impairment (review)
Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None
vs: None
Outcome: None
효과: None
None
대상 집단: None
Other
Milk Fat Globules: 2024 Updates.
Dose: None
vs: None
Outcome: Inflammatory markers
효과: None
None
대상 집단: None
Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None
vs: None
Outcome: Cognitive function
효과: None
None
대상 집단: Alzheimer's disease patients
Key Statistics
18
연구
3200
참여자
↑
Positive
B
등급
Referenced Papers
European journal of …
2025
8 인용
Nutrients
2025
6 인용
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Systematic Review
International journal of …
2025
2 인용
Journal of cutaneous …
2025
European journal of …
2024
16 인용
Lasers in medical …
2024
10 인용
Healthcare (Basel, Switzerland)
2024
9 인용
Newborn (Clarksville, Md.)
2024
9 인용
Cureus
2024
8 인용
Journal of cosmetic …
2024
1 인용
American family physician
2024
Current opinion in …
2023
58 인용
Nutrition reviews
2023
18 인용
Archives of dermatological …
2023
3 인용
Vitamin Supplementation and Dementia: A Systematic Review.
Systematic Review
Nutrients
2022
76 인용
Brain, behavior, and …
2022
64 인용
European journal of …
2022
63 인용
The American journal …
2022
18 인용
Journal of Ayub …
2022
4 인용
The effects of twenty-one nutrients and phytonutrients on cognitive function: A narrative review.
Review
Journal of clinical …
2021
38 인용
Antioxidants (Basel, Switzerland)
2021
33 인용
Diet enriched in omega-3 fatty acids alleviates olfactory system deficits in APOE4 transgenic mice.
Other
The European journal …
2021
4 인용
The Senior care …
2021
2 인용
Nutrients
2020
72 인용
Journal of cutaneous …
2020
21 인용
Psychiatrike = Psychiatriki
2020
15 인용
Journal of Alzheimer's …
2020
14 인용
FASEB journal : …
2020
8 인용
Omega-3 fatty acids and cognitive decline: a systematic review.
Systematic Review
Nutricion hospitalaria
2019
40 인용
Alzheimer's research & …
2019
29 인용
The journal of …
2018
24 인용
Journal of Alzheimer's …
2018
12 인용
FASEB journal : …
2017
41 인용
Actas espanolas de …
2017
22 인용
FASEB journal : …
2017
21 인용
Current Alzheimer research
2017
7 인용
Journal of Alzheimer's …
2016
128 인용
NeuroImage
2016
118 인용
FP essentials
2016
11 인용
Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.
Meta-Analysis
Climacteric : the …
2015
92 인용
Journal of Alzheimer's …
2015
8 인용
European journal of …
2014
204 인용
Nutrition (Burbank, Los …
2014
74 인용
Acta clinica Belgica
2014
44 인용
Nutricion hospitalaria
2014
17 인용
Advances in nutrition …
2013
155 인용
Journal of Alzheimer's …
2012
257 인용
Journal of Alzheimer's …
2012
137 인용
Alzheimer disease and …
2011
52 인용
Molecular neurobiology
2010
145 인용
Journal of Alzheimer's …
2010
110 인용
Journal of Alzheimer's …
2010
55 인용
Women's health (London, …
2010
48 인용
JAMA
2009
304 인용
Progress in neuro-psychopharmacology …
2008
388 인용
Alternative medicine review …
2008
Alternative medicine review …
2007
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
일반적으로 사용되는 용량
- general:
- 1,000-2,000 mg combined DHA/EPA per day
- cognitivesupport:
- 1,000-1,700 mg/day (optimal dose-response curve)
상한량: 3,000 mg/day combined DHA/EPA (FDA GRAS)
연구에서 사용된 용량
| 용량 | 기간 | 효과 | N |
|---|---|---|---|
| None | -- | Mixed | 3582 |
| IL triamcinolone every 4 weeks + calcipotriol twice daily | 12 weeks | Positive | 73 |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| Vitamin D3 vs triamcinolone acetonide | 12 weeks | Positive | 40 |
| None | -- | Positive | -- |
권장 복용 시간: With meals containing fat for better absorption
Safety & Side Effects
보고된 부작용
- ⚠ Fishy aftertaste or burping
- ⚠ Mild gastrointestinal discomfort
- ⚠ Potential increased bleeding time at very high doses
- ⚠ May lower blood pressure slightly
알려진 상호작용
- ● Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
- ● Blood pressure medications (additive hypotensive effect)
- ● Orlistat (may reduce omega-3 absorption)
일일 최대 섭취 허용량: 3,000 mg/day combined DHA/EPA (FDA GRAS)
건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.
Frequently Asked Questions
Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.
Related Evidence
관련 다른 성분: Mild Cognitive Impairment (MCI)
Omega-3 Fatty Acids (DHA/EPA) 다른 건강 상태에 대한 근거
FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.